{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Spyre Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"SYRE"},"Address":{"label":"Address","value":"805 LAS CIMAS PARKWAY,SUITE 100, AUSTIN, Texas, 78746, United States"},"Phone":{"label":"Phone","value":"+1 512 942-2935"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage."},"CompanyUrl":{"label":"Company Url","value":"https://www.spyre.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Brian Connolly","title":"Chief Technical Officer"},{"name":"Cameron Turtle","title":"Chief Executive Officer & Director"},{"name":"Ivan Noches","title":"Vice President-Information Technology"},{"name":"Janet Gunzner-Toste","title":"Senior Vice President-Operations"},{"name":"Scott W. Rowlinson","title":"Vice President-Research"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}